Global immunoassay market to rise by $8.64b through 2028

Thanks to predictive and preventive medicine.

The global immunoassay market is projected to grow by $8.64b until 2028 at a compound annual growth rate of 4.42%, said Technavio.

The sector’s expansion is attributed to a trend towards predictive and preventive medicine for early diagnosis and treatment.

“The demand for immunoassay kits, reagents, and instruments is on the rise, driven by the need for accurate and reliable diagnostic results,” the report said.

The market is also fuelled by advancements such as improvements in chemiluminescence, biosensors, microfluidic devices, and automation.

It is expected to continue its upward trajectory, particularly in developing countries due to their expanding healthcare infrastructure and population needs.